The overactivation of coagulation in the initial phase of COVID-19, generating high levels of D-dimers, thrombocytopenia, and moderate prothrombin time prolongation (Thomson et al., 2020), seems to be caused by the combined action of MASP-1/MASP-2 and thrombin. Here, MASP1 is linked to COVID-19.